EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Screen‐positive rate in cell‐free DNA screening for microdeletion 22q11.2

Kai Lüthgens iD, Monika Sinzel, Miriam Kolar, Karl Oliver Kagan iD

Prenatal Diagnosis · 2023

DOI: 10.1002/pd.6328 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Prenatal Diagnosis, 2023. Verfasst von Kai Lüthgens und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cenata GmbH, Tuebingen, Germany. Hauptthemen laut MEDLINE: Cell-Free Nucleic Acids. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To examine the impact of the fetal fraction (FF) on the screen‐positive rate in screening for microdeletion 22q11.2.

Methods

This study is based on samples that were analyzed using the Harmony® Prenatal Test (Roche Inc). The study cohort comprised samples from women with singleton pregnancies who were at least 16 years old and at least at 11 weeks' gestation. Logistic regression analysis was used to determine significant covariates that carry an impact on the screen‐positive rate.

Results

The study population consisted of 52,019 pregnancies, including 309 pregnancies with a high‐risk result for microdeletion 22q11.2. Thus, the overall screen‐positive rate was 0.59%. In the low‐risk group, the FF was 10.1%, and in the high‐risk group, it was 7.3%. Regression analysis indicated a strong correlation between the FF and the screen‐positive rate. In the cases with an FF of

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell-Free Nucleic AcidsPregnancyHumansFemaleAdolescentPrenatal DiagnosisRisk FactorsFetusGestational Age

Substanzen

Cell-Free Nucleic Acids

Autor:innen und Institutionen

  • Cenata GmbH, Tuebingen, Germany.
  • Department of Women's Health, University Women's Hospital, Tuebingen, Germany.

ORCID-Profile: Kai Lüthgens, Karl Oliver Kagan

Zitieren

APA

Lüthgens, K., Sinzel, M., Kolar, M., & Kagan, K. O. (2023). Screen‐positive rate in cell‐free DNA screening for microdeletion 22q11.2. Prenatal Diagnosis. https://doi.org/10.1002/pd.6328

Vancouver

Lüthgens K, Sinzel M, Kolar M, Kagan KO. Screen‐positive rate in cell‐free DNA screening for microdeletion 22q11.2. Prenatal Diagnosis. 2023. doi:10.1002/pd.6328

BibTeX
@article{Lthgens2023,
  author = {Lüthgens, Kai and Sinzel, Monika and Kolar, Miriam and Kagan, Karl Oliver},
  title = {Screen‐positive rate in cell‐free DNA screening for microdeletion 22q11.2},
  journal = {Prenatal Diagnosis},
  year = {2023},
  doi = {10.1002/pd.6328}
}
Kostenlos starten →